Fas (CD95) signalling is best known for its role in apoptosis, however, recent reports have shown it to be involved in other cellular responses as well, including inflammation. Fas and its adaptor protein FADD are known to negatively regulate LPS-induced proinflammatory responses, but their role in LPS-induced type I interferon production is unknown. Here, we demonstrate that Fas engagement on macrophages, using an agonistic Fas antibody CH11, augments LPS-induced NF-jB responses, causing increased production of TNFa, IL-8, IL-6 and IL-12. Conversely, costimulation with both LPS and CH11 causes a significant reduction in the level of interferon-beta (IFNb) production. This differential effect involves the Fas adaptor FADD because while LPS-induced IL-6 production increased in FADD À/À murine embryonic fibroblasts, LPS-induced IFNb production was significantly reduced in these cells. Overexpression of a dominant negative form of FADD (FADD-DD) inhibits LPS-induced IFNb luciferase but not LPS-induced NF-jB luciferase. In contrast, overexpression of full-length FADD inhibited LPS-induced NF-jB luciferase activation but was seen to augment LPSinduced IFNb luciferase. Moreover, FADD-DD inhibits TRIF-, TRAM-, IKKe-, TBK-1-and TRAF3-induced IFNb luciferase production, with coimmunoprecipitation experiments demonstrating an interaction between FADD and TRIF. These data identify FADD as a novel component of the noncanonical Toll-like receptor 4/IFNb signalling pathway and demonstrate that both Fas and its adaptor FADD can differentially regulate the production of LPS-induced proinflammatory cytokines and type I interferons.
Introduction
Fas, (APO-1/CD95), is a 45-kDa glycosylated type-1 transmembrane protein, possessing a death domain (DD) in its C-terminal portion. Fas is best studied in terms of its role in apoptosis and is well recognized as a key activator of caspase-dependant apoptosis [1] . Upon binding of its cognate ligand Fas Ligand (FasL), the adaptor protein Fas-associated Death Domain (FADD) is recruited to Fas although a homotypic DD-DD interaction, facilitating the formation of the death-inducing signalling complex (DISC). Formation of the DISC facilitates the recruitment of procaspase-8 to this complex with its subsequent activation, ultimately culminating in the induction of apoptosis [2] . More recent studies have, however, demonstrated that Fas signalling mediates additional cellular functions, such as proliferation, migration, activation and maturation of dendritic cells, and activation of the inflammatory response [3, 4] . Indeed, multiple reports have now demonstrated the ability of Fas to trigger production of cytokines and chemokines in many cell types following activation of transcription factors such as NF-jB and MAP kinases [5, 6] .
Toll-like receptors (TLRs) are critical components of the innate immune response that detect microorganisms through the recognition of conserved molecular motifs called pathogen-activated molecular patterns [7] . TLR4 is essential for recognition of Gram-negative lipopolysaccharide (LPS), with recognition of LPS by TLR4 resulting in a sequential activation of several downstream signalling cascades culminating in potent activation of immune and inflammatory genes. Initially, recognition of LPS by TLR4 results in recruitment of the adaptor proteins MyD88 and Mal, resulting in rapid activation of NF-jB and MAPKs. Following activation of the MyD88/Mal signalling cascade, TLR4 becomes internalized, allowing for recruitment of the adapter proteins TRAM and TRIF, and activation of the second arm of the TLR4 signalling pathway, the MyD88-independent pathway. Activation of the MyD88-independent pathway results predominantly in the production of type I interferons (IFN) [8] .
Given that coexpression of TLR4 and Fas is found on a multitude of cell types, the ability of Fas activation to modify TLR4-induced inflammatory responses has been investigated in several studies. Interruption of the Fas signalling pathway was shown to preserve cardiac function following LPS exposure, with blockade of Fas signalling resulting in a reduction in IL-6 and TNFa production by peritoneal macrophages [9] . Similarly, mice lacking expression of Fas (lpr) or FasL (gld) demonstrate a reduction in TLR4-mediated NFjB activation and cytokine production [10] . Crosstalk has also been demonstrated in intestinal epithelial cells with a reduction of Fas expression shown to markedly reduce the ability of LPS to induce IL-8 expression [6] . Crosstalk can also occur in the opposite direction, with Fas-induced HMGB1 release and associated cytokine production shown to be significantly decreased in TLR4 À/À macrophages [11] .
The role of the Fas adaptor FADD in TLR4 signalling has also been examined in several studies. FADD has been characterized as a negative regulator of the TLR4-MyD88-dependant signalling pathway, as a reduction in FADD expression results in augmented IL-6 production in response to LPS stimulation [10, 12] . FADD has been shown to mediate this negative regulatory effect through a DD-DD interaction with MyD88, sequestering MyD88 and IRAK1 in an inactive complex in the cytosol, thus limiting TLR4-induced MyD88-dependant cytokine expression. Upon activation of Fas, FADD is recruited to the Fas DISC, thereby releasing FADD from this MyD88 complex, alleviating its repression on MyD88-dependant signalling [13] . These studies did not, however, investigate the effect of Fas ligation or FADD on TLR4-induced type I IFN expression.
Here, we show that Fas ligation exerts opposing effects on the MyD88-dependant and MyD88-independent arms of the TLR4 signalling pathway, as activation of Fas augments LPS-induced NF-jB-dependant cytokine expression while decreasing LPS-induced IFNb production. A similar divergent effect on both arms of the TLR4 signalling pathway is seen following both suppression of, and overexpression of FADD, thereby identifying FADD as a critical signalling component of LPS-induced IFNb production. Together these findings identify FADD as a novel component of the TLR4-IFNb signalling pathway and demonstrate a role for Fas ligation in modulating the outcome of the TLR4-signalling pathway.
Results

Stimulation of macrophages with LPS induces Fas expression, whereas stimulation of Fas does not increase TLR4 expression
While it has been previously established that LPS and other TLR ligands increase expression of both Fas in several cell types [6, 14] , it is unclear as to whether this is a bi-directional regulatory effect. In order to establish this, we initially investigated the ability of LPS to induce Fas and FasL expression. THP-1 macrophages were stimulated with increasing doses of LPS and demonstrated a clear dose-dependent increase in expression of Fas (Fig. 1a,c,d ). Interestingly, FasL expression was seen to increase at the mRNA level (Fig. 1b ) but not at the protein level (Fig. 1c,d) did not augment expression of TLR4 at either the mRNA (Fig. 1e) or protein (Fig. 1f) level.
Fas activation augments the expression of LPSinduced NF-jB-dependant genes but decreases IFNb expression
In order to further characterize the crosstalk between Fas and TLR4, we next examined the effect of stimulation of THP-1 macrophages with both LPS and CH11. It has previously been reported that simultaneous activation of Fas and TLR4 increases the ability of LPS to induce gene expression in macrophages [10] and intestinal epithelial cells [6] . In these reports, however, predominantly NF-jB-dependant genes were examined and as such the effect of such a costimulation of Fas and TLR4 on IRF-dependent genes is poorly characterized. We observed a clear augmentation in mRNA levels of several key NF-jB-dependant genes such as TNFa, IL-6, IL-12 and IL-8 following costimulation of THP-1 macrophages with both LPS and CH11 (Fig. 2a) . In addition, costimulation of Fas and TLR4 augmented IL-8 protein levels (Fig. 2b) . In contrast, costimulation of THP-1 macrophages with LPS and CH11 resulted in a marked reduction in the ability of LPS to induce IFNb as assessed by qRT-PCR (Fig. 2c) and ELISA (Fig. 2d) . In order to confirm that this was neither a cell linespecific nor species-specific effect, similar experiments were performed in murine-immortalized bone marrowderived macrophages (iBMDM). Increased surface expression of Fas was confirmed by flow cytometry in the iBMDMs following LPS stimulation (Fig. 3a) . Costimulation of these cells with a murine agonistic Fas antibody (Jo-2) augmented the level of IL-6 mRNA and protein induced by LPS (Fig. 3b) while significantly decreasing the ability of LPS to induce IFNb (Fig. 3c) . Similar findings were observed with human monocyte-derived macrophages (hMDMs). Expression of Fas was increased following LPS treatment (Fig. 3d) . Moreover, costimulation with CH11 and LPS resulted in augmented protein levels of IL-8 and decreased protein levels of IFNb ( IFNb mRNA and protein levels were detected by qRT-PCR and ELISA, respectively, in the iBMDMs (B and C). Changes in IL-8 and IFNb protein levels were detected by ELISA in the hMDMs (E). Data are shown as mean values AE SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001. P values calculated by one-way ANOVA with Tukey's post-test.
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Alterations in cytokine production occurs independently of Fas-mediated apoptosis
Given the well-characterized apoptotic function of Fas, we next investigated whether the altered cytokine production by macrophages following CH11 stimulation was coupled with Fas-mediated apoptosis. Stimulation of THP-1 macrophages (Fig. 4a) , hMDMs ( Fig. 4b) and iBMDMs ( Fig. 4c) with either LPS or CH11 did not result in enhanced caspase 3/7 activation. These results are consistent with previous studies, whereby activation of Fas in THP-1 cells did not trigger apoptotic cell death [15] . To confirm that CH11 was able to induce apoptosis in Fas-sensitive cells, Jurkat T cells were treated with CH11, which resulted in strong caspase 3/7 activation (Fig. 4) . Together these data indicate that the altered cytokine profile was not associated with CH11-induced apoptosis.
The Fas adaptor FADD differentially affects LPSinduced inflammatory responses
In order to understand the mechanism underlying the ability of Fas engagement to augment LPS-induced production of genes such as TNFa, IL-8 and IL-6, while reducing expression of IFNb, we initially investigated the role of the Fas adaptor FADD. FADD has been previously reported to act as an inhibitor of LPSinduced NF-jB activation, through its interaction with MyD88 [13] . Using wild-type (WT) and FADD knockout murine embryonic fibroblasts (MEFs), we confirmed the inhibitory effect of FADD on NF-jBdependant gene expression. The ability of LPS to induce IL-6 was increased fivefold in the FADD
MEF as compared to WT MEF (Fig. 5a ). In contrast, we observed a 50% reduction in IFNb production in the FADD À/À MEF as compared to WT MEF (Fig. 5b) . Consistent with this, the ability of LPS to induce phosphorylation of IRF-3 in these cells was significantly impaired in the absence of FADD, with reduced and later activation of IRF3 observed in the FADD À/À MEF as compared to WT MEF (Fig. 5c ).
In contrast, phosphorylation of the NF-kB subunit p65, was seen to occur at an earlier time point in the absence of FADD (Fig. 5c) . In order to further examine this differential effect of FADD on LPS-induced inflammatory responses, RAW264.7 macrophages were transfected with an NF-jB luciferase reporter construct and transfected with either full-length FADD or a dominant negative form of FADD, the FADD-death domain (FADD-DD also known as FADD-DN) and subsequently stimulated with LPS. Overexpression of FADD were transfected with either an NF-jB -luciferase (D) or an IFNb luciferase (E) construct and a TK-renilla reporter constructs for 18 h. Cells were also transfected with plasmids encoding either FADD or FADD-DD. Cells were stimulated with LPS (100 ngÁmL À1 ) for 6 h prior to lysis. Luciferase activity was measured and expressed as fold-change over renilla activity. Changes in protein expression were quantified by densitometry and normalized to untreated (C). Results are representative of three independent experiments. Data are shown as mean values AE SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001. P values in (A) were analysed using two-way ANOVA, followed by a subsequent student t-test on the individual stimulations. P values in (D) and (E) were calculated by one-way ANOVA with Tukey's post-test.
inhibited the ability of LPS to induce NF-jB luciferase production by over 50%, whereas the FADD-DD had no effect (Fig. 5d) . In contrast, the opposite effect was observed upon overexpression of these constructs with the IFNb luciferase reporter. Overexpression of the FADD-DD potently inhibited the ability of LPS to induce an IFNb luciferase construct, whereas fulllength FADD had no effect (Fig. 5e ). The preceding results indicate that, while acting as an inhibitor of the TLR4-induced MyD88-dependant pathway, FADD may play a role as an active signalling component of the MyD88-independent pathway. In order to further examine this, overexpression experiments were performed using FADD constructs together with the four adaptors of the TLR4 signalling pathway, MyD88, Mal, TRIF and TRAM. Overexpression of full-length FADD increased the ability of both TRIF and TRAM to induce both ISRE-and IFNb luciferase (Fig. 6a) . In contrast, overexpression of full-length FADD inhibited both MyD88-and Malinduced NF-jB luciferase activation (Fig. 6a) , in keeping with its known role as an inhibitor of MyD-88 induced NF-jB. Consistent with this, overexpression of dominant negative FADD-DD inhibited induction of both ISRE and IFNb luciferase in response to TRIF and TRAM (Fig. 6b) , while overexpression of the FADD-DD was seen to have no effect on MyD88-and Mal-induced NF-jB activation (Fig. 6b ). As these data indicated that FADD may be a component of the noncanonical TLR4 pathway, we further investigated the effect of the FADD-DD on components of this pathway and observed that the FADD-DD was able to inhibit TBK-1-, IKKe-and TRAF3-induced IFNb luciferase production (Fig. 6c) . As these data indicated that FADD may be interacting at the level of the adaptor proteins, coimmunoprecipitation experiments were performed to determine interacting partners for FADD. Epitope-tagged expression constructs of TRIF and FADD were overexpressed in HEK293 cells, with a complex between these proteins detected following specific immunoprecipitation (Fig. 6d, lane 4) .
FADD does not appear to play a role in TLR7/8 signalling
As we had previously shown a role for FADD in TLR3 signalling [16] and data presented here demonstrate a role for FADD in the noncanonical TLR4 signalling pathway, we wished to examine whether this function of FADD extends to additional TLRs that are known to activate type I IFNs, such as TLRs 7 and 8, or whether it is specific to those TLRs that utilize the adaptor TRIF. THP1-derived macrophages have previously been shown to express TLR7/8 [17] and activation of these receptors leads to proinflammatory cytokine production [18] . To investigate this, THP-1 macrophages were stimulated with combinations of LPS, CH11 and R848 (TLR7/8 ligand). While data shown in Fig. 7 show that CH11 modulated LPSinduced responses as seen in Fig. 2 , CH11 had no effect on the ability of R848 to induce IL-8, TNFa or IFNb.
Discussion
It has long been appreciated that two discrete signalling pathways are associated with TLR4; the MyD88-dependant and MyD88-independent pathways which respectively result in either a potent NF-jB response or potent type I IFN production. Here, we have shown that both Fas activation and expression of FADD play opposing effects on these two arms of the TLR4 pathway. The majority of studies that have examined the synergistic effect following co-ordinated activation of both Fas and TLR signalling have focussed on NF-jB-dependant TLR4 responses, which are significantly enhanced upon stimulation of Fas.
One of the first reports to characterize this crosstalk demonstrated that LPS-sensitized macrophages produce enhanced levels of IL-1b in response to Fas stimulation relative to nonsensitized cells [14] . Similarly, mice lacking Fas (lpr) display reduced arthritis as compared to WT mice using the collagen-induced arthritis model, while blockade of Fas signalling using an antagonistic FasL antibody reduced LPS-induced IL-6 and TNFa production by macrophages [10] . However, in these studies, the effect of costimulation of TLR4 and Fas on type I IFN production was not examined. Our data demonstrate that, in contrast to the ability to Fas activation to enhance LPS-induced NF-jB responses, Fas activation reduced LPS-induced IFNb production. It is clear, therefore, that there is greater complexity in the crosstalk between Fas and TLRs that has been previously appreciated. Type I IFN production is known to play an important role in the host defence against certain Gram-negative bacterial infections [19, 20] . However, excessive production of type I IFNs during bacterial infection can also have detrimental effects. Inhibition of immune responses by type I IFNs has been shown to be deleterious during infection with the facultative intracellular Gram-negative bacterium Francisella novicida. Moreover, IFNb exacerbates infection with Salmonella typhimurium by reducing the ability of the host to launch a complete immune response [21] . These studies highlight the importance of tightly regulating IFNb production in response to Gram-negative bacteria in order to avoid detrimental excessive inflammation and associated pathologies. Given the wealth of regulatory mechanisms that are known to exist regarding TLR-mediated NF-jB activation, there are still relatively fewer known regulators of either LPS-induced IFNb production or other TRIF-mediated TLR signalling pathways [22] . Our findings demonstrate a novel mechanism of regulation of LPS-induced IFNb production via activation of the Fas receptor. As the physiological ligand for Fas is FasL, which displays the highest endogenous level of expression on activated T cells [1] , our findings imply that following bacterial infection and activation of T cells, Fas expressed on macrophages present at the site of infection may become ligated by FasL. This would potentially suppress TLR4-mediated IFNb production, thereby regulating IFN production in response to bacterial infection. The Fas adaptor FADD has been shown to play an inhibitory function in TLR4-mediated cytokine and chemokine production. FADD interacts with MyD88 and IRAK1 to negatively regulate MyD88-dependant cytokine production [13] . Our data presented here not only confirms this effect but, in addition, establishes an opposing role for FADD as a novel component of the noncanonical TLR4 signalling pathway, being required for TLR4-mediated IFNb production. A critical role for FADD in the induction of type I IFN has been previously shown in response to intracellular dsRNA [23] . FADD knockout MEFs demonstrate lower levels of IFN production in response to vesicular stomatis virus (VSV) infection as compared to WT MEF [23] . In a separate study, this group demonstrated that FADD was essential for RIG-I-, MDA5-and MAVS/IPS-1-induced IFNb production and is also required for PolyI:C-induced IRF7 expression [24] . Our findings highlight that FADD appears to be a signalling component utilized across multiple innate immune pathways in the induction of type I IFNs.
Given our findings that FADD is able to interact with TRIF and facilitate LPS-mediated IFNb induction, we were interested to establish whether this function of FADD extends to additional TLRs that are known to activate type I IFNs. TLRs 7 and 8 are potent activators of type I IFN production but do not utilize the adaptor TRIF. Instead, these TLRs utilize the adaptor MyD88 to activate NF-jB and IFN pathways. Interestingly, we observed no effect following ligation of Fas with CH11 on R848-induced activation of either NFjB-or IFNb-driven inflammatory responses. This indicates that not only does it seem that the role for FADD in activation of IFNb is limited to TLRs 3 and 4 which utilize TRIF but also that the specificity of FADD as an inhibitor of MyD88-induced NFjB activation may be TLR4 specific. It is possible that the interaction observed between FADD and MyD88/IRAK1 [13] requires the presence of the TLR4 adaptor Mal which is absent from the TLR7 and TLR8 signalling pathways.
In conclusion, our results provide insight into the mechanisms that determine the balance of production of type I IFNs and proinflammatory cytokines in innate immune responses and also provide further evidence and insight into the nonapoptotic functions of Fas signalling. 
Experimental procedures
Isolation of human monocyte-derived macrophages
Blood samples were collected from healthy volunteers and monocytes extracted using Histopaque-1077 (Sigma-Aldrich Company Ltd. 
Caspase 3/7 assay
Cells were seeded overnight in black flat-bottomed 96-well plates at a density of 20 000 cells/well, treated with CH11 and 100 ngÁmL À1 LPS for 24 h, or were treated with each agonist separately. Apo-ONE caspase-3/7 reagent was added and following 1 h incubation, fluorescence (485 excitation, 530 emission) was measured using a GENios Microplate Reader (Tecan Group Ltd, M€ annedorf, Switzerland).
Changes in caspase 3/7 activation were normalized relative to untreated cells. . Stimulations involving LPS were performed for 6 h prior to lysis of cells. Cells were lysed in Passive Lysis Buffer (10 mM EDTA, 100 mM DTT, 50% glycerol, 5% Triton X-100, 125 mM Tris base, pH 7.8). Luminescent activity was then measured on Promega GloMax system (Madison, WI, USA).
Luciferase assays
Coimmunoprecipitation experiments
HEK293T cells were seeded overnight in 10-cm dishes at 1 9 10 5 cellsÁmL À1 and transfected the following day with 0.5 lg of HA-TRIF and with 1 lg of FLAG-FADD. These concentrations were deemed optimal following analysis of cell death associated with overexpression of the TRIF construct. Cells were lysed on ice for 1 h in 1 mL of RIPA buffer (50 mM Tris-HCL pH8.0, 150 mM NaCl, 0.1% NaCl, 0.1% SDS, 0.5% Sodium Deoxycholate, 1% Triton X-100, 1 mM PMSF) supplemented with protease and phosphatase inhibitor cocktail. An aliquot of lysate was removed for whole cell lysate analysis. Lysates were precleared twice with protein A beads (Santa Cruz Biotechnology). Precleared cell-free extracts were incubated with fresh protein A-agarose beads and either anti-FLAG antibody (Sigma-Aldrich Company Ltd.) or anti-HA antibody (Abcam, Cambridge UK) for 4 h at 4°C. The immune complexes were washed three times in immunoprecipitation buffer and eluted by the addition of sample buffer followed by SDS/PAGE and immunoblotting using the indicated antibodies.
Statistics
Experiments were performed a minimum of three times in triplicate. All results, with the exception of MEF experiments were statistically evaluated using one-way ANOVA with Tukey's post-test. MEF experiments were analysed using two-way ANOVA, followed by a subsequent Student's t-test on the individual stimulations. Values of P < 0.001 are indicated by three asterisks (***). Values of P < 0.01 are indicated by two asterisks (**). Values of P < 0.05 are indicated by one asterisk (*).
